0001209191-18-052365.txt : 20180926
0001209191-18-052365.hdr.sgml : 20180926
20180926184721
ACCESSION NUMBER: 0001209191-18-052365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180726
FILED AS OF DATE: 20180926
DATE AS OF CHANGE: 20180926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ratcliffe Liam
CENTRAL INDEX KEY: 0001547100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 181089132
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE - SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unum Therapeutics Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-26
0
0001622229
Unum Therapeutics Inc.
UMRX
0001547100
Ratcliffe Liam
C/O UNUM THERAPEUTICS INC.
200 CAMBRIDGE PARK DRIVE, SUITE 3100
CAMBRIDGE
MA
02140
1
0
0
0
Stock Option (Right to Buy)
14.57
2018-07-26
4
A
0
1504
8.72
A
2028-07-26
Common Stock
1504
1504
D
The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
This option is fully vested at time of grant.
/s/ Amoli Pandya, as Attorney-in-Fact
2018-09-26